Literature DB >> 15175062

Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome.

Koichi Mizumaki1, Akira Fujiki, Takayuki Tsuneda, Masao Sakabe, Kunihiro Nishida, Masataka Sugao, Hiroshi Inoue.   

Abstract

INTRODUCTION: In Brugada syndrome, ventricular fibrillation (VF) occurs mainly during sleep, and Brugada ECG signs are intensified by parasympathomimetic drugs; therefore, vagal activity could be a precipitating factor of VF. The aim of the present study was to elucidate the relation between spontaneous augmentation of ST elevation and changes in autonomic nervous activities in the daily life of patients with Brugada syndrome. METHODS AND
RESULTS: Twenty-three consecutive patients with Brugada syndrome were studied. Group VF(+) consisted of 7 symptomatic patients and 3 asymptomatic patients with inducible VF; group VF(-) consisted of 13 asymptomatic patients without documented or inducible VF. Two-channel unipolar lead (V(1) and V(2)) Holter ECG was recorded. Heart rate variability was analyzed by the maximum entropy method. Spontaneous augmentation of ST elevation (>/=1.5 mm/20 min) occurred more frequently during 24 hours in group VF(+) than in group VF(-) (5.7 +/- 2.5 times vs 2.3 +/- 2.4 times, P < 0.01). ST elevation was significantly greater in group VF(+) than in group VF(-) (2.1 +/- 0.2 mm vs 1.8 +/- 0.2 mm, P < 0.05). Power of the high-frequency component (HF: 0.15-0.4 Hz) and RR interval increased progressively, and the ratio of low-frequency component (LF; 0.04- 0.15 Hz) to high-frequency component (LF/HF) gradually decreased toward the time of maximum ST elevation. During an entire day, daytime (0-5 P.M.), and nighttime (0-5 A.M.), both HF and LF/HF were not different between groups VF(+) and VF(-).
CONCLUSION: In Brugada syndrome, spontaneous augmentation of ST elevation in daily life occurred along with an increase in vagal activity. ST elevation was augmented more in patients with VF than in those without VF under similar vagal tone.

Entities:  

Mesh:

Year:  2004        PMID: 15175062     DOI: 10.1046/j.1540-8167.2004.03601.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  34 in total

1.  Diurnal variation of frequency domain T-wave alternans on 24-hour ambulatory electrocardiogram in subjects without heart disease: Significant effect of autonomic nervous activity of the heart.

Authors:  Kenichi Hashimoto; Yuji Kasamaki; Masayoshi Soma; Bonpei Takase
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-11-07       Impact factor: 1.468

2.  Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation.

Authors:  Markéta Bébarová; Tom O'Hara; Jan L M C Geelen; Roselie J Jongbloed; Carl Timmermans; Yvonne H Arens; Luz-Maria Rodriguez; Yoram Rudy; Paul G A Volders
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

Review 3.  Cardiac sodium channel mutations: why so many phenotypes?

Authors:  Man Liu; Kai-Chien Yang; Samuel C Dudley
Journal:  Nat Rev Cardiol       Date:  2014-06-24       Impact factor: 32.419

4.  Marijuana Induced Type I Brugada Pattern: A Case Report.

Authors:  Pramod Theetha Kariyanna; Apoorva Jayarangaiah; Sudhanva Hegde; Jonathan D Marmur; Perry Wengrofsky; Mena Yacoub; Michael Post; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2018-08-07

5.  Multiple serial ECGs aid with the diagnosis and prognosis of Brugada syndrome.

Authors:  Jesus Castro Hevia; Margarita Dorantes Sanchez; Frank Martinez Lopez; Osmin Castañeda Chirino; Roylan Falcon Rodriguez; Marcelo Puga Bravo; Joanna de Zayas Galguera; Charles Antzelevitch
Journal:  Int J Cardiol       Date:  2018-08-30       Impact factor: 4.164

6.  Autonomic modulation of the electrical substrate in mice haploinsufficient for cardiac sodium channels: a model of the Brugada syndrome.

Authors:  Malcolm Finlay; Justine Bhar-Amato; Keat-Eng Ng; Diogo Santos; Michele Orini; Vishal Vyas; Peter Taggart; Andrew A Grace; Christopher L-H Huang; Pier D Lambiase; Andrew Tinker
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-10       Impact factor: 4.249

Review 7.  Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2006-10       Impact factor: 1.976

Review 8.  Sudden cardiac death without structural heart disease: update on the long QT and Brugada syndromes.

Authors:  Ilan Goldenberg; Arthur J Moss; Wojciech Zareba
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

Review 9.  Pathogenesis and management of Brugada syndrome.

Authors:  Juan Sieira; Gregory Dendramis; Pedro Brugada
Journal:  Nat Rev Cardiol       Date:  2016-09-15       Impact factor: 32.419

10.  Ventricular tachycardia in a Brugada syndrome patient caused by a novel deletion in SCN5A.

Authors:  J Tfelt-Hansen; T Jespersen; J Hofman-Bang; H Borger Rasmussen; P Cedergreen; F Skovby; H Abriel; J Hastrup Svendsen; Soren-Peter Olesen; M Christiansen; S Haunso
Journal:  Can J Cardiol       Date:  2009-03       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.